Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Idilman, R; Cetinkaya, H; Savas, I; Aslan, N; Sak, SD; Bastemir, M; Sarioglu, M; Soykan, I; Bozdayi, M; Colantoni, A; Aydmtug, O; Bahar, K; Uzunalimoglu, O; Van Thiel, DH; Numanoglu, N; Dokmeci, A
   Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C
   JOURNAL OF MEDICAL VIROLOGY
   
   R. Idilman et al., "Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C", J MED VIROL, 66(1), 2002, pp. 34-39
2. Salemi, M; Vandamme, AM
   Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences
   JOURNAL OF MOLECULAR EVOLUTION
   
   M. Salemi e A.M. Vandamme, "Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences", J MOL EVOL, 54(1), 2002, pp. 62-70
3. Weidauer, H
   Saliva as a germ carrier
   LARYNGO-RHINO-OTOLOGIE
   
   H. Weidauer, "Saliva as a germ carrier", LARY RH OTO, 80, 2001, pp. S26-S60
4. Andreone, P; Gramenzi, A; Cursaro, C; Biselli, M; Di Giammarino, L; Grazi, GL; Jovine, E; D'Errico, A; Galli, S; Mazziotti, A; Cavallari, A; Bernardi, M
   Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study
   DIGESTIVE AND LIVER DISEASE
   
   P. Andreone et al., "Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study", DIG LIVER D, 33(8), 2001, pp. 693-697
5. Romero-Gomez, M; Grande, L; Nogales, MC; Fernandez, M; Chavez, M; Castro, M
   Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption
   DIGESTIVE AND LIVER DISEASE
   
   M. Romero-Gomez et al., "Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption", DIG LIVER D, 33(8), 2001, pp. 698-702
6. De Mitri, MS; Cassini, R; Morsica, G; Bagaglio, S; Zoli, M; Bernardi, M
   New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication
   DIGESTIVE AND LIVER DISEASE
   
   M.S. De Mitri et al., "New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication", DIG LIVER D, 33(7), 2001, pp. 591-594
7. De Filippi, F; Lampertico, P; Soffredini, R; Rumi, MG; Lunghi, G; Aroldi, A; Tarantino, A; Ponticelli, C; Colombo, M
   High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients
   DIGESTIVE AND LIVER DISEASE
   
   F. De Filippi et al., "High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients", DIG LIVER D, 33(6), 2001, pp. 477-479
8. Mazzoran, L; Zorat, F; Chemello, L; Croce, LS; Rigato, I; Cavalletto, L; Bernardinello, E; Tiribelli, C; Alberti, A; Pozzato, G
   Human leucocyte interferon-alpha in the treatment of chronic hepatitis C
   DIGESTIVE AND LIVER DISEASE
   
   L. Mazzoran et al., "Human leucocyte interferon-alpha in the treatment of chronic hepatitis C", DIG LIVER D, 33(4), 2001, pp. 347-352
9. Caprioli, F; Pometta, R; Visentin, S; Massironi, S; Conte, D
   "Hepatitic flare", asthenia, peripheral polyneuropathy and diffuse liver steatosis in a hepatitis C virus asymptomatic chronic carrier
   DIGESTIVE AND LIVER DISEASE
   
   F. Caprioli et al., ""Hepatitic flare", asthenia, peripheral polyneuropathy and diffuse liver steatosis in a hepatitis C virus asymptomatic chronic carrier", DIG LIVER D, 33(4), 2001, pp. 359-362
10. Valentini, P; Mariotti, P; Ngalikpima, CJ; Angelone, DF; Ranno, O
    Seizures in an interferon-treated child
    DIGESTIVE AND LIVER DISEASE
    
    P. Valentini et al., "Seizures in an interferon-treated child", DIG LIVER D, 33(4), 2001, pp. 363-365
11. Conte, D; Colucci, A; Minola, E; Fraquelli, M; Prati, D
    Clinical course of pregnant women with chronic hepatitis C virus infectionand risk of mother-to-child hepatitis C virus transmission
    DIGESTIVE AND LIVER DISEASE
    
    D. Conte et al., "Clinical course of pregnant women with chronic hepatitis C virus infectionand risk of mother-to-child hepatitis C virus transmission", DIG LIVER D, 33(4), 2001, pp. 366-371
12. Cimino, L; Oriani, G; D'Arienzo, A; Manguso, F; Loguercio, C; Ascione, A; Caporaso, N; Blanco, CD; Budillon, G
    Interactions between metabolic disorders [diabetes, gallstones, and dyslipidaemia] and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey
    DIGESTIVE AND LIVER DISEASE
    
    L. Cimino et al., "Interactions between metabolic disorders [diabetes, gallstones, and dyslipidaemia] and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey", DIG LIVER D, 33(3), 2001, pp. 240-246
13. Morisco, F; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; Del Buono, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, N; Carella, C
    Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C
    DIGESTIVE AND LIVER DISEASE
    
    F. Morisco et al., "Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C", DIG LIVER D, 33(3), 2001, pp. 247-253
14. Tabor, E
    Hepatocellular carcinoma: global epidemiology
    DIGESTIVE AND LIVER DISEASE
    
    E. Tabor, "Hepatocellular carcinoma: global epidemiology", DIG LIVER D, 33(2), 2001, pp. 115-117
15. Puoti, M; Cadeo, GP; Putzolu, V; Forleo, MA; Barni, MC; Cristini, G; Rossi, S; Spinetti, A; Zaltron, S; Zanini, B; Quiros-Roldan, E; Paraninfo, G; Gargiulo, F; Carosi, G
    Pilot dose-finding trial on interferon alpha in combination with ribavirinfor the treatment of chronic hepatitis C in patients not responding to interferon alone
    DIGESTIVE AND LIVER DISEASE
    
    M. Puoti et al., "Pilot dose-finding trial on interferon alpha in combination with ribavirinfor the treatment of chronic hepatitis C in patients not responding to interferon alone", DIG LIVER D, 33(2), 2001, pp. 163-172
16. Weinstein, T; Tur-Kaspa, R; Chagnac, A; Korzerts, A; Ori, Y; Zevin, D; Herman, M; Gafter, U
    Hepatitis C infection in dialysis patients in Israel
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    T. Weinstein et al., "Hepatitis C infection in dialysis patients in Israel", ISR MED ASS, 3(3), 2001, pp. 174-177
17. Hill, AVS
    The genomics and genetics of human infectious disease susceptibility
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
    
    A.V.S. Hill, "The genomics and genetics of human infectious disease susceptibility", ANN REV GEN, 2, 2001, pp. 373-400
18. Berenguer, M; Rayon, JM; Prieto, M; Aguilera, V; Nicolas, D; Ortiz, V; Carrasco, D; Lopez-Andujar, R; Mir, J; Berenguer, J
    Are posttransplantation protocol liver biopsies useful in the long term?
    LIVER TRANSPLANTATION
    
    M. Berenguer et al., "Are posttransplantation protocol liver biopsies useful in the long term?", LIVER TRANS, 7(9), 2001, pp. 790-796
19. Eason, JD; Loss, GE; Blazek, J; Nair, S; Mason, AL
    Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial
    LIVER TRANSPLANTATION
    
    J.D. Eason et al., "Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial", LIVER TRANS, 7(8), 2001, pp. 693-697
20. Gish, RG; Lee, A; Brooks, L; Leung, J; Lau, JYN; Moore, DH
    Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation
    LIVER TRANSPLANTATION
    
    R.G. Gish et al., "Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation", LIVER TRANS, 7(7), 2001, pp. 581-587
21. Yoshida, EM; Buczkowski, AK; Giulivi, A; Zou, SM; Forrester, LA
    A cross-sectional study of SEN virus in liver transplant recipients
    LIVER TRANSPLANTATION
    
    E.M. Yoshida et al., "A cross-sectional study of SEN virus in liver transplant recipients", LIVER TRANS, 7(6), 2001, pp. 521-525
22. Blanco, JJ; Herrero, JI; Quiroga, J; Sangro, B; Gomez-Manero, N; Pardo, F; Cienfuegos, JA; Prieto, J
    Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse events
    LIVER TRANSPLANTATION
    
    J.J. Blanco et al., "Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse events", LIVER TRANS, 7(3), 2001, pp. 226-233
23. Haydon, G; Neuberger, J
    Liver transplantation in cirrhotic patients with diabetes mellitus
    LIVER TRANSPLANTATION
    
    G. Haydon e J. Neuberger, "Liver transplantation in cirrhotic patients with diabetes mellitus", LIVER TRANS, 7(3), 2001, pp. 234-237
24. Jonsson, JR; Hong, C; Purdie, DM; Hawley, C; Isbel, N; Butler, M; Balderson, GA; Clouston, D; Pandeya, N; Stuart, K; Edwards-Smith, C; Crawford, DH; Fawcett, J; Powell, EE
    Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation
    LIVER TRANSPLANTATION
    
    J.R. Jonsson et al., "Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation", LIVER TRANS, 7(3), 2001, pp. 255-263
25. Reuben, A
    Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity
    LIVER TRANSPLANTATION
    
    A. Reuben, "Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity", LIVER TRANS, 7(11), 2001, pp. S13-S21
26. Levy, GA
    Long-term immunosuppression and drug interactions
    LIVER TRANSPLANTATION
    
    G.A. Levy, "Long-term immunosuppression and drug interactions", LIVER TRANS, 7(11), 2001, pp. S53-S59
27. Amberg, S; Engels, JW
    Phenylalkyl backbone modified oligodeoxynucleotides, their synthesis and the influence of the alkyl chain length
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    
    S. Amberg e J.W. Engels, "Phenylalkyl backbone modified oligodeoxynucleotides, their synthesis and the influence of the alkyl chain length", NUCLEOS NUC, 20(4-7), 2001, pp. 1275-1278
28. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
    Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A.D. Monforte et al., "Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART", J ACQ IMM D, 28(2), 2001, pp. 114-123
29. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
    Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M. Nunez et al., "Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy", J ACQ IMM D, 27(5), 2001, pp. 426-431
30. Colon, HM; Robles, RR; Deren, S; Sahai, H; Finlinson, HA; Andia, J; Cruz, MA; Kang, SY; Oliver-Velez, D
    Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    H.M. Colon et al., "Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico", J ACQ IMM D, 27(4), 2001, pp. 405-413
31. Duong, M; Petit, JM; Piroth, L; Grappin, M; Buisson, M; Chavanet, P; Hillon, S; Portier, H
    Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M. Duong et al., "Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy", J ACQ IMM D, 27(3), 2001, pp. 245-250
32. Thorpe, LE; Bailey, SL; Huo, DZ; Monterroso, ER; Ouellet, LJ
    Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999)
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    L.E. Thorpe et al., "Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999)", J ACQ IMM D, 27(1), 2001, pp. 71-78
33. Daar, ES; Lynn, H; Donfield, S; Gomperts, E; Hilgartner, MW; Hoots, WK; Chernoff, D; Arkin, S; Wong, WY; Winkler, CA
    Relation between HIV-1 and hepatitis C viral load in patients with hemophilia
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    E.S. Daar et al., "Relation between HIV-1 and hepatitis C viral load in patients with hemophilia", J ACQ IMM D, 26(5), 2001, pp. 466-472
34. Bonacini, M; Lin, HJ; Hollinger, FB
    Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M. Bonacini et al., "Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus", J ACQ IMM D, 26(4), 2001, pp. 340-344
35. Lai, S; Liu, W; Chen, J; Yang, J; Li, ZJ; Li, RJ; Liang, FX; Liang, SL; Zhu, QY; Yu, XF
    Changes in HIV-1 incidence in heroin users in Guangxi Province, China
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S. Lai et al., "Changes in HIV-1 incidence in heroin users in Guangxi Province, China", J ACQ IMM D, 26(4), 2001, pp. 365-370
36. Diaz, T; Vlahov, D; Greenberg, B; Cuevas, Y; Garfein, R
    Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    
    T. Diaz et al., "Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem", J WOMEN H G, 10(4), 2001, pp. 371-380
37. Luqmani, RA; Robinson, H
    Introduction to, and classification of, the systemic vasculitides
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    R.A. Luqmani e H. Robinson, "Introduction to, and classification of, the systemic vasculitides", BEST PR R C, 15(2), 2001, pp. 187-202
38. Levine, SM; Stone, JH
    New approaches to treatment in systemic vasculitis: biological therapies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    S.M. Levine e J.H. Stone, "New approaches to treatment in systemic vasculitis: biological therapies", BEST PR R C, 15(2), 2001, pp. 315-333
39. Chapel, HM; Christie, JML; Peach, V; Chapman, RWG
    Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C
    CLINICAL IMMUNOLOGY
    
    H.M. Chapel et al., "Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C", CLIN IMMUNO, 99(3), 2001, pp. 320-324
40. Anthony, DD; Post, AB; Valdez, H; Peterson, DL; Murphy, M; Heeger, PS
    ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producingperipheral blood lymphocytes in infected humans with and without cirrhosis
    CLINICAL IMMUNOLOGY
    
    D.D. Anthony et al., "ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producingperipheral blood lymphocytes in infected humans with and without cirrhosis", CLIN IMMUNO, 99(2), 2001, pp. 232-240
41. Ohsawa, I; Ohi, H; Tamano, M; Endo, M; Fujita, T; Satomura, A; Hidaka, M; Fuke, Y; Matsushita, M; Fujita, T
    Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway
    CLINICAL IMMUNOLOGY
    
    I. Ohsawa et al., "Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway", CLIN IMMUNO, 101(1), 2001, pp. 59-66
42. Wu, JZ
    Internally located signal peptides direct hepatitis C virus polyprotein processing in the ER membrane
    IUBMB LIFE
    
    J.Z. Wu, "Internally located signal peptides direct hepatitis C virus polyprotein processing in the ER membrane", IUBMB LIFE, 51(1), 2001, pp. 19-23
43. Fujino, Y; Mizoue, T; Tokui, N; Yoshimura, T
    Prospective study of diabetes mellitus and liver cancer in Japan
    DIABETES-METABOLISM RESEARCH AND REVIEWS
    
    Y. Fujino et al., "Prospective study of diabetes mellitus and liver cancer in Japan", DIABET M R, 17(5), 2001, pp. 374-379
44. Rewald, E; Francischetti, MM; Nydegger, UE
    IVIG-pools: regulatory gifts - Transiting from harmony toward harmonious immunoglobulins: Why? and why not?
    TRANSFUSION AND APHERESIS SCIENCE
    
    E. Rewald et al., "IVIG-pools: regulatory gifts - Transiting from harmony toward harmonious immunoglobulins: Why? and why not?", TRANSF AP S, 25(2), 2001, pp. 113-137
45. Vagner, S; Galy, B; Pyronnet, S
    Irresistible IRES - Attracting the translation machinery to internal ribosome entry sites
    EMBO REPORTS
    
    S. Vagner et al., "Irresistible IRES - Attracting the translation machinery to internal ribosome entry sites", EMBO REP, 2(10), 2001, pp. 893-898
46. Chambers, AJ; Lord, RSA
    Documented prevalence of HIV and hepatitis C infection in patients with penetrating trauma
    ANZ journal of surgery
    
    A.J. Chambers e R.S.A. Lord, "Documented prevalence of HIV and hepatitis C infection in patients with penetrating trauma", AUST NZ J S, 71(1), 2001, pp. 21-23
47. Sasadeusz, J
    Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones
    INTERNAL MEDICINE JOURNAL
    
    J. Sasadeusz, "Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones", INTERN M J, 31(7), 2001, pp. 418-421
48. Ostapowicz, G; Dallinger, M; Bell, SJ; Strasser, SI; Watson, KJR; Slavin, J; Santamaria, J; Desmond, PV
    Changes in hepatitis C-related liver disease in a large clinic population
    INTERNAL MEDICINE JOURNAL
    
    G. Ostapowicz et al., "Changes in hepatitis C-related liver disease in a large clinic population", INTERN M J, 31(2), 2001, pp. 90-96
49. Kobayashi, J; Hashimoto, T
    The measurement of anti-hepatitis C virus antibody in sera using a new generation immunoassay
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    J. Kobayashi e T. Hashimoto, "The measurement of anti-hepatitis C virus antibody in sera using a new generation immunoassay", CLIN CH L M, 39(2), 2001, pp. 173-174
50. Stote, RH
    Analysis of the RGD sequence in protein structures: comparison to the conformations of the RGDW and (D)RGDW peptides determined by molecular dynamicssimulations
    THEORETICAL CHEMISTRY ACCOUNTS
    
    R.H. Stote, "Analysis of the RGD sequence in protein structures: comparison to the conformations of the RGDW and (D)RGDW peptides determined by molecular dynamicssimulations", THEOR CH AC, 106(1-2), 2001, pp. 128-136
51. Moradpour, D; Cerny, A; Heim, MH; Blum, HE
    Hepatitis C: an update
    SWISS MEDICAL WEEKLY
    
    D. Moradpour et al., "Hepatitis C: an update", SWISS MED W, 131(21-22), 2001, pp. 291-298
52. Eiz-Vesper, B; Maiworm, M; Harpain, O; Fuchs, N; Mohr, H; Pring-Akerblom, P
    Prevalence and sequence variability of GBV-C genomes among blood donors inNorthern Germany
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    B. Eiz-Vesper et al., "Prevalence and sequence variability of GBV-C genomes among blood donors inNorthern Germany", INFUS THER, 28(3), 2001, pp. 130-134
53. Hutschenreuter, G; Kiese, M; Wessiepe, M
    Introduction of a central documentation of blood products according to 14 and 17 transfusiongesetz (TFG) by a computerized blood bank data system
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    G. Hutschenreuter et al., "Introduction of a central documentation of blood products according to 14 and 17 transfusiongesetz (TFG) by a computerized blood bank data system", INFUS THER, 28(1), 2001, pp. 20-23
54. Boucheix, C; Rubinstein, E
    Tetraspanins
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    C. Boucheix e E. Rubinstein, "Tetraspanins", CELL MOL L, 58(9), 2001, pp. 1189-1205
55. Kumar, KS; Roice, M; Sasikumar, PG; Poduri, CD; Sugunan, VS; Pillai, VNR; Das, MR
    Syntheses of immunodominant peptide regions of hepatitis C viral pathogensusing PS-BDODMA resin: a single peptide derived from the conserved domain (E2/NS1) was highly effective in detecting anti-HCV antibodies
    JOURNAL OF PEPTIDE RESEARCH
    
    K.S. Kumar et al., "Syntheses of immunodominant peptide regions of hepatitis C viral pathogensusing PS-BDODMA resin: a single peptide derived from the conserved domain (E2/NS1) was highly effective in detecting anti-HCV antibodies", J PEPT RES, 57(2), 2001, pp. 140-150
56. Price, P; Mathiot, N; Krueger, R; Stone, S; Keane, NM; French, MA
    Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy
    JOURNAL OF CLINICAL VIROLOGY
    
    P. Price et al., "Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy", J CLIN VIRO, 22(3), 2001, pp. 279-287
57. Schinkel, J; Kroes, ACM; Wagtmans, MJ; Lamers, CBHW; van Hoek, B
    Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays
    JOURNAL OF CLINICAL VIROLOGY
    
    J. Schinkel et al., "Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays", J CLIN VIRO, 22(1), 2001, pp. 61-71
58. Thelu, MA; Baud, M; Leroy, V; Seigneurin, JM; Zarski, JP
    Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients
    JOURNAL OF CLINICAL VIROLOGY
    
    M.A. Thelu et al., "Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients", J CLIN VIRO, 22(1), 2001, pp. 125-131
59. Levis, J; Kenny-Walsh, E; O'Sullivan, K; Horgan, M; Whelton, M; Shanahan, F; Fanning, L
    Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification
    JOURNAL OF CLINICAL VIROLOGY
    
    J. Levis et al., "Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification", J CLIN VIRO, 20(3), 2001, pp. 163-171
60. Haushofer, AC; Kopty, C; Hauer, R; Brunner, H; Halbmayer, WM
    HCV genotypes and age distribution in patients of Vienna and surrounding areas
    JOURNAL OF CLINICAL VIROLOGY
    
    A.C. Haushofer et al., "HCV genotypes and age distribution in patients of Vienna and surrounding areas", J CLIN VIRO, 20(1-2), 2001, pp. 41-47
61. Valentine-Thon, E
    Borderline and/or discordant Cobas Amplicor (TM) HCV Test Version 2.0 results: clinical significance
    JOURNAL OF CLINICAL VIROLOGY
    
    E. Valentine-Thon, "Borderline and/or discordant Cobas Amplicor (TM) HCV Test Version 2.0 results: clinical significance", J CLIN VIRO, 20(1-2), 2001, pp. 77-80
62. Moriyama, M; Zhao, ZY; Wu, LR; Wang, XQ; Ohshiro, S; Iwasaki, H; Ichijima, S; Iwaguchi, K; Matsumura, H; Sugitani, M; Komiyama, K; Arakawa, Y
    Clinico-epidemiological study of GBV-C/HGV infection in Tokyo metropolitan, and Nanjing and Yanbian cities in the People's Republic of China
    HEPATOLOGY RESEARCH
    
    M. Moriyama et al., "Clinico-epidemiological study of GBV-C/HGV infection in Tokyo metropolitan, and Nanjing and Yanbian cities in the People's Republic of China", HEPATOL RES, 21(3), 2001, pp. 268-279
63. Tanimoto, K; Akbar, SMF; Michitaka, K; Horiike, N; Onji, M
    Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis
    HEPATOLOGY RESEARCH
    
    K. Tanimoto et al., "Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis", HEPATOL RES, 21(2), 2001, pp. 117-125
64. Arase, Y; Chayama, K; Ikeda, K; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Suzuki, F; Akuta, N; Someya, T; Kobayashi, M; Kumada, H
    Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    Y. Arase et al., "Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C", HEPATOL RES, 21(1), 2001, pp. 55-66
65. Murawaki, Y; Ikuta, Y; Koda, M; Kawasaki, H
    Comparison of clinical laboratory liver tests between asymptomatic HBV andHCV carriers with persistently normal aminotransferase serum levels
    HEPATOLOGY RESEARCH
    
    Y. Murawaki et al., "Comparison of clinical laboratory liver tests between asymptomatic HBV andHCV carriers with persistently normal aminotransferase serum levels", HEPATOL RES, 21(1), 2001, pp. 67-75
66. Tokita, H; Murai, S; Kamitsukasa, H; Yagura, M; Harada, H; Takahashi, M; Okamoto, H
    Influence of TT virus infection on the thrombocytopenia of patients with chronic liver disease
    HEPATOLOGY RESEARCH
    
    H. Tokita et al., "Influence of TT virus infection on the thrombocytopenia of patients with chronic liver disease", HEPATOL RES, 20(3), 2001, pp. 288-300
67. Suou, T; Mitsuda, A; Koda, M; Matsuda, H; Maruyama, S; Tanaka, H; Kishimoto, Y; Michimori, K; Hirooka, Y; Kawasaki, H
    Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study
    HEPATOLOGY RESEARCH
    
    T. Suou et al., "Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study", HEPATOL RES, 20(3), 2001, pp. 301-311
68. Okanoue, T; Daimon, Y; Kirishima, T; Ohnishi, N; Nakamura, H; Nagao, Y; Minami, M; Itoh, Y
    Retreatment with interferon-alpha at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients
    HEPATOLOGY RESEARCH
    
    T. Okanoue et al., "Retreatment with interferon-alpha at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients", HEPATOL RES, 20(3), 2001, pp. 348-358
69. Bacosi, M; Patsouri, M; Miglioresi, L; Patrizi, F; Russo, F; Ricci, GL
    Combined treatment of HCV infection: is there a need for meta-analysis?
    HEPATOLOGY RESEARCH
    
    M. Bacosi et al., "Combined treatment of HCV infection: is there a need for meta-analysis?", HEPATOL RES, 20(3), 2001, pp. 359-371
70. Takahashi, K; Iwata, K; Matsumoto, M; Matsumoto, H; Nakao, K; Hatahara, T; Ohta, Y; Kanai, K; Maruo, H; Baba, K; Hijikata, M; Mishiro, S
    Hepatitis C virus (HCV) genotype 1b sequences from fifteen patients with hepatocellular carcinoma: the 'progression score' revisited
    HEPATOLOGY RESEARCH
    
    K. Takahashi et al., "Hepatitis C virus (HCV) genotype 1b sequences from fifteen patients with hepatocellular carcinoma: the 'progression score' revisited", HEPATOL RES, 20(2), 2001, pp. 161-171
71. Mahmood, S; Nakata, K; Sho, M; Kimura, T; Manabe, Y; Kinoyama, S; Ito, T; Yamada, G
    Clinical usefulness of the branched DNA assay version 2 in predicting the efficacy of Interferon treatment in a group of chronic HCV patients based on serotype
    HEPATOLOGY RESEARCH
    
    S. Mahmood et al., "Clinical usefulness of the branched DNA assay version 2 in predicting the efficacy of Interferon treatment in a group of chronic HCV patients based on serotype", HEPATOL RES, 20(1), 2001, pp. 9-17
72. Fujie, H; Moriya, K; Shintani, Y; Tsutsumi, T; Takayama, T; Makuuchi, M; Kimura, S; Koike, K
    Frequent beta-catenin aberration in human hepatocellular carcinoma
    HEPATOLOGY RESEARCH
    
    H. Fujie et al., "Frequent beta-catenin aberration in human hepatocellular carcinoma", HEPATOL RES, 20(1), 2001, pp. 39-51
73. Chu, CW; Hwang, SJ; Luo, JC; Wang, YJ; Lu, RH; Lai, CR; Tsay, SH; Li, CP; Wu, JC; Chang, FY; Lee, SD
    Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    C.W. Chu et al., "Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C", HEPATOL RES, 19(3), 2001, pp. 225-236
74. Jaiswal, SPB; Chitnis, DS; Jain, AK; Inamdar, S; Porwal, A; Jain, SC
    Prevalence of hepatitis viruses among multi-transfused homogenous thalassaemia patients
    HEPATOLOGY RESEARCH
    
    S.P.B. Jaiswal et al., "Prevalence of hepatitis viruses among multi-transfused homogenous thalassaemia patients", HEPATOL RES, 19(3), 2001, pp. 247-253
75. Nakamuta, M; Shimohashi, N; Tada, S; Kinukawa, N; Enjoji, M; Uchimura, K; Motomura, K; Sugimoto, R; Kato, M; Iwamoto, H; Kuniyoshi, M; Sakai, H; Nawata, H
    Serum levels of HCV RNA and core protein before and after incubation at 37degrees C for 24 h
    HEPATOLOGY RESEARCH
    
    M. Nakamuta et al., "Serum levels of HCV RNA and core protein before and after incubation at 37degrees C for 24 h", HEPATOL RES, 19(3), 2001, pp. 254-262
76. Omagari, K; Matsuo, I; Ohba, K; Masuda, J; Hazama, H; Sakimura, K; Kinoshita, H; Tsurutani, H; Isomoto, H; Murase, K; Kohno, S
    Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis
    HEPATOLOGY RESEARCH
    
    K. Omagari et al., "Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis", HEPATOL RES, 19(3), 2001, pp. 263-269
77. Goto, J; Nishimura, S; Esumi, M; Makizumi, K; Rikihisa, T; Nishihara, T; Mizuno, K; Zhou, YH; Shikata, T; Fujiyama, S; Tomita, K
    Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1
    HEPATOLOGY RESEARCH
    
    J. Goto et al., "Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1", HEPATOL RES, 19(3), 2001, pp. 270-283
78. Hwang, SJ; Lee, SD; Chu, CW; Lu, RH; Chang, FY
    An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    S.J. Hwang et al., "An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C", HEPATOL RES, 19(3), 2001, pp. 284-293
79. Yagura, M; Murai, S; Kojima, H; Tokita, H; Kamitsukasa, H; Harada, H
    Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?
    HEPATOLOGY RESEARCH
    
    M. Yagura et al., "Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?", HEPATOL RES, 19(2), 2001, pp. 144-157
80. El-Zayadi, AR; Abaza, H; Shawky, S; Mohamed, MK; Selim, OE; Badran, HM
    Prevalence and epidemiological features of hepatocellular carcinoma in Egypt - a single center experience
    HEPATOLOGY RESEARCH
    
    A.R. El-Zayadi et al., "Prevalence and epidemiological features of hepatocellular carcinoma in Egypt - a single center experience", HEPATOL RES, 19(2), 2001, pp. 170-179
81. Arase, Y; Ikeda, K; Chayama, K; Murashima, N; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Kobayashi, M; Suzuki, F; Kumada, H
    Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
    HEPATOLOGY RESEARCH
    
    Y. Arase et al., "Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration", HEPATOL RES, 19(1), 2001, pp. 22-30
82. Vaughan, CK; Sollazzo, M
    Of minibody, camel and bacteriophage
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    
    C.K. Vaughan e M. Sollazzo, "Of minibody, camel and bacteriophage", COMB CHEM H, 4(5), 2001, pp. 417-430
83. Smikle, M; Dowe, G; Hylton-Kong, T; Williams, E
    Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica
    SEXUALLY TRANSMITTED INFECTIONS
    
    M. Smikle et al., "Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica", SEX TRANS I, 77(4), 2001, pp. 295-296
84. Read, SJ
    Recovery efficiencies of nucleic acid extraction kits as measured by quantitative LightCycler (TM) PCR
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    S.J. Read, "Recovery efficiencies of nucleic acid extraction kits as measured by quantitative LightCycler (TM) PCR", J CL PATH-M, 54(2), 2001, pp. 86-90
85. Bari, A; Akhtar, S; Rahbar, MH; Luby, SP
    Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    A. Bari et al., "Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan", TR MED I H, 6(9), 2001, pp. 732-738
86. Dunne, EA; Quayle, E
    The impact of iatrogenically acquired hepatitis C infection on the well-being and relationships of a group of Irish women
    JOURNAL OF HEALTH PSYCHOLOGY
    
    E.A. Dunne e E. Quayle, "The impact of iatrogenically acquired hepatitis C infection on the well-being and relationships of a group of Irish women", J HEAL PSYC, 6(6), 2001, pp. 679-692
87. Beales, LP; Rowlands, DJ; Holzenburg, A
    The internal ribosome entry site (IRES) of hepatitis C virus visualized byelectron microscopy
    RNA-A PUBLICATION OF THE RNA SOCIETY
    
    L.P. Beales et al., "The internal ribosome entry site (IRES) of hepatitis C virus visualized byelectron microscopy", RNA, 7(5), 2001, pp. 661-670
88. Walewski, JL; Keller, TR; Stump, DD; Branch, AD
    Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame
    RNA-A PUBLICATION OF THE RNA SOCIETY
    
    J.L. Walewski et al., "Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame", RNA, 7(5), 2001, pp. 710-721
89. Kanamori, Y; Nakashima, N
    A tertiary structure model of the internal ribosome entry site (IRES) for methionine-independent initiation of translation
    RNA-A PUBLICATION OF THE RNA SOCIETY
    
    Y. Kanamori e N. Nakashima, "A tertiary structure model of the internal ribosome entry site (IRES) for methionine-independent initiation of translation", RNA, 7(2), 2001, pp. 266-274
90. Stassinopoulos, IA; Belsham, GJ
    A novel protein-RNA binding assay: Functional interactions of the foot-and-mouth disease virus internal ribosome entry site with cellular proteins
    RNA-A PUBLICATION OF THE RNA SOCIETY
    
    I.A. Stassinopoulos e G.J. Belsham, "A novel protein-RNA binding assay: Functional interactions of the foot-and-mouth disease virus internal ribosome entry site with cellular proteins", RNA, 7(1), 2001, pp. 114-122
91. Henderson, L; Muir, M; Mills, PR; Spence, E; Fox, R; McCruden, EAB; Bagg, J
    Oral health of patients, with hepatitis C virus infection: a pilot study
    ORAL DISEASES
    
    L. Henderson et al., "Oral health of patients, with hepatitis C virus infection: a pilot study", ORAL DIS, 7(5), 2001, pp. 271-275
92. Mega, H; Jiang, WW; Takagi, M
    Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus
    ORAL DISEASES
    
    H. Mega et al., "Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus", ORAL DIS, 7(5), 2001, pp. 296-305
93. Zein, NN
    Experimental and emerging therapies for chronic hepatitis C virus infection
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    N.N. Zein, "Experimental and emerging therapies for chronic hepatitis C virus infection", EXPERT OP I, 10(8), 2001, pp. 1457-1469
94. Macejak, DG; Jensen, KL; Pavco, PA; Phipps, KM; Heinz, BA; Colacino, JM; Blatt, LM
    Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA
    JOURNAL OF VIRAL HEPATITIS
    
    D.G. Macejak et al., "Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA", J VIRAL HEP, 8(6), 2001, pp. 400-405
95. Pianko, S; Patella, S; Ostapowicz, G; Desmond, P; Sievert, W
    Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection
    JOURNAL OF VIRAL HEPATITIS
    
    S. Pianko et al., "Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection", J VIRAL HEP, 8(6), 2001, pp. 406-413
96. Yoshioka, K; Kobayashi, M; Orito, E; Watanabe, K; Yano, M; Sameshima, Y; Kusakabe, A; Hirofuji, H; Fuji, A; Kuriki, J; Arao, M; Murase, K; Mizokami, M; Kakumu, S
    Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection
    JOURNAL OF VIRAL HEPATITIS
    
    K. Yoshioka et al., "Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection", J VIRAL HEP, 8(6), 2001, pp. 421-429
97. Korenaga, M; Hino, K; Katoh, Y; Yamaguchi, Y; Okuda, M; Yoshioka, K; Okita, K
    A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization
    JOURNAL OF VIRAL HEPATITIS
    
    M. Korenaga et al., "A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization", J VIRAL HEP, 8(5), 2001, pp. 331-340
98. Itoh, Y; Morita, A; Nishioji, K; Narumi, S; Toyama, T; Daimon, Y; Nakamura, H; Kirishima, T; Okanoue, T
    Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels
    JOURNAL OF VIRAL HEPATITIS
    
    Y. Itoh et al., "Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels", J VIRAL HEP, 8(5), 2001, pp. 341-348
99. Takagi, H; Nagamine, T; Abe, T; Takayama, H; Sato, K; Otsuka, T; Kakizaki, S; Hashimoto, Y; Matsumoto, T; Kojima, A; Takezawa, J; Suzuki, K; Sato, S; Mori, M
    Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    H. Takagi et al., "Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C", J VIRAL HEP, 8(5), 2001, pp. 367-371
100. De Maria, N; Idilman, R; Colantoni, A; Van Thiel, DH
     Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis
     JOURNAL OF VIRAL HEPATITIS
     
     N. De Maria et al., "Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis", J VIRAL HEP, 8(5), 2001, pp. 372-376